Opus Genetics’ Promising Prospects: Buy Rating Reinforced by OPGx-LCA5 Efficacy and Strategic Advancements
Analyst Debanjana Chatterjee of JonesTrading reiterated a Buy rating on Opus Genetics, retaining the price target of $6.00.…
Browsing Tag